里程碑!FDA首次批准AI工具助力新药研发

Med新声
Dec 09, 2025

12月8日路透社消息,FDA宣布,已正式批准首款人工智能(AI)工具用于药物临床试验中重度脂肪肝疾病的评估工作。该工具名为AIM-NASH,将面向所有相关药物研发项目开放使用,为代谢相关脂肪性肝炎(MASH)的新药研发按下“加速键”。作为一款云端系统,AIM-NASH的核心功能是通过AI算法分析肝组织图像,精准识别脂肪堆积、炎症反应、组织瘢痕等疾病关键特征,并依据标准评分体系生成评估结果,最终由...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10